===================== Product Identification =====================
MSDS NAME:0201-05/4600-01 HYPERSTAT IV INJECTION
NIIN:00-334-4478
MSDS Number: BWXRC
=== Responsible Party ===
Company:SCHERING CORP
Address:2000 GALLOPING HILL RD
City:KENILWORTH
State:NJ
ZIP:07033-5000
Country:US
Info Phone Num:908-298-5044
Emergency Phone Num:908-298-5044
CAGE:SCHER
=== Contractor Identification ===
Company:SCHERING CORP
Address:2000 GALLOPING HILL RD
City:KENILWORTH
State:NJ
ZIP:07033-5000
Country:US
Phone:908-298-5044
CAGE:SCHER
============= Composition/Information on Ingredients =============
Name:DIAZOXIDE *95-1*
CAS:364-98-7
RTECS #:DK8185000
Fraction by Wt: 1.5%
Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000
Fraction by Wt: 98.5%
===================== Hazards Identification =====================
Routes of Entry: Inhalation:YES Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INHALATION: UNDILUTED PRODUCT MAY
CAUSE SENSITIZATION/ALLERGIC REACTIONS IN THE THROAT/LUNGS.
SKIN/EYES: UNDILUTED PRODUCT MAY CAUSE IRRITATION. INGESTION:
UNDILUTED PRODUCT MAY PRODUCE RESPONSES IN S ENSATIVE INDIVIDUALS.
DIAZOXIDE CAN CAUSE A RAPID DECREASE IN BLOOD PRESSURE. (SEE SUPP)
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION, RASH, ARRHYTHMIAS, CONVULSIONS,
SHOCK, NAUSEA, VOMITING, MENTAL DEPRESSION, DIZZINESS, WEAKNESS,
DECREASE IN BLOOD PRESSURE
Medical Cond Aggravated by Exposure:THOSE W/CONDITIONS OF DIABETES
MELLITUS, IMPAIRED CEREBRAL/CARDIAC CIRCULATION
======================= First Aid Measures =======================
First Aid:INHALATION: REMOVE FROM EXPOSURE. IF NOT BREATHING, GIVE CPR.
SKIN: WASH W/SOAP & WATER. EYES: FLUSH W/WATER FOR 15 MINS.
INGESTION: GIVE COPIOUS AMOUNTS OF WATER & INDUCE VOMITING, IF
CONSCIOUS. OBTA IN MEDICAL ATTENTION IN ALL CASES.
===================== Fire Fighting Measures =====================
Flash Point:>200F
Extinguishing Media:WATER, WATER SPRAY, CO2, DRY CHEMICAL
Fire Fighting Procedures:FIGHT FIRE FROM A SAFE DISTANCE/PROTECTED
LOCATION. USE WATER SPRAY TO KEEP EXPOSED CONTAINERS & EQUIPMENT
COOL. WEAR FULL PROTECTIVE CLOTHING & SCBA.
Unusual Fire/Explosion Hazard:NOT UNDER NORMAL CONDITIONS OF USE.
================== Accidental Release Measures ==================
Spill Release Procedures:MINIMIZE CONTACT W/MATERIAL. KEEP PERSONNEL
AWAY FROM AREA. WEAR RESPIRATORY PROTECTION & CLOTHING. SQUEEGIE,
SCOOP, ABSORB/USE A VACUUM TO CLEAN UP. CLEAN AREA W/AN ALKALINE
CLEANER/DETERGENT. DISPOS E OF MATERIAL.
====================== Handling and Storage ======================
Handling and Storage Precautions:STORE IN A COOL, DRY, WELL VENTILATED
AREA. USE INDICATED PROTECTIVE EQUIPMENT WHILE HANDLING.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:A HALF MASK RESPIRATOR W/ORGANIC VAPOR/ACID
GAS/HIGH EFFICIENCY CARTRIDGES MAY BE USED FOR HANDLING THE
MATERIAL IN BULK.
Ventilation:ADEQUATE LOCAL EXHAUST FOR USE OF THE MATERIAL IN BULK.
Protective Gloves:LATEX
Eye Protection:SAFETY GLASSES W/SIDE SHIELDS
Other Protective Equipment:LAB COAT, UNIFORM
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE. WASH HANDS & FOREARMS AFTER EACH USE.
Supplemental Safety and Health
HEALTH HAZ CONT'D: HYPERSTAT IV INJECTION CONTAINS DIAZOXIDE WHICH CAN
CAUSE SODIUM & WATER RETENTION, HYPERGLYCEMIA, MYOCARDIAL &
CEREBRAL ISCHEMIA, HYPERURICEMIA, HYPERTENSION, PANCREATITIS,
TRANSIE NT CATERACTS. DIAZOXIDE CAN CROSS THE PACENTAL BARRIER &
MAY POSSESS TERATOGENIC PROPERTIES.
================== Physical/Chemical Properties ==================
Appearance and Odor:CLEAR, COLORLESS LIQUID
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
OXIDIZERS, STRONG ACIDS & BASES
Stability Condition to Avoid:OPEN FLAME, HIGH TEMPERATURES
Hazardous Decomposition Products:CO, CO2
==================== Disposal Considerations ====================
Waste Disposal Methods:MATERIAL SHOULD BE DISPOSED OF BY INCINERATION
IN ACCORDANCE W/LOCAL, STATE & FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|
|